Breathe Well Live Well
Conditions: Anisakis; Allergy; Occupational Exposure
Intervention: Other: Questionnaire
Sponsors: University Hospital, Lille; Institut Pasteur de Lille; ANSES, Boulogne-sur-Mer; Région Nord-Pas de Calais, France
Active, not recruiting – verified January 2016
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Infectious Diseases
Intervention: Other: No Intervention
Sponsors: Helmholtz Centre for Infection Research; Hannover Medical School
Recruiting – verified January 2016
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Conditions: Asthma; Rhinovirus; Picornaviridae Infections; Common Cold
Interventions: Drug: OC459; Drug: Placebo; Other: Rhinovirus
Sponsors: Imperial College London; Medical Research Council; Atopix Therapeutics, Ltd.
Recruiting – verified January 2016
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Conditions: Individuality; Healthy; Asthma; Immune System and Related Disorders
Intervention: Biological: Pneumococcal Vaccination
Sponsor: Michigan State University
Recruiting – verified January 2016
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Asthma
Interventions: Drug: Mepolizumab 100mg SC; Drug: Albuterol/salbutamol MDIs; Drug: Omalizumab
Sponsor: GlaxoSmithKline
Not yet recruiting – verified January 2016
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Asthma
Intervention: Behavioral: asthma APP
Sponsor: Shanghai Children’s Medical Center
Not yet recruiting – verified January 2016
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Asthma
Interventions: Drug: Fluticasone / Salmeterol; Drug: Placebo; Drug: Advair Diskus 100/50
Sponsors: Roxane Laboratories; Vectura Limited
Completed – verified January 2016
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Conditions: Asthma; Chronic Obstructive Pulmonary Disease (COPD)
Interventions: Drug: AZD7594 inhalation powder (200 ?g); Drug: AZD7594 inhalation powder (400 ?g); Drug: AZD7594 pressurized inhalation suspension (200 ?g); Drug: AZD7594 placebo inhalation powder; Drug: AZD7594 placebo pressurized inhalation suspension
Sponsor: AstraZeneca
Not yet recruiting – verified December 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Radiographic Contrast Agent Nephropathy
Interventions: Other: Hydration with bicarbonate in addition to theophylline; Other: Hydration with sodium chloride in addition to theophylline
Sponsor: Technische Universität München
Completed – verified December 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Conditions: Brachial Plexus Block; Anesthetics, Local
Interventions: Drug: Ropivacaine 0.5%; Drug: Ropivacaine 1%; Drug: Bupivacaine 0.5% + epinephrine 1:200,000
Sponsor: Sunnybrook Health Sciences Centre
Not yet recruiting – verified December 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days